- Mekhoa ea phekolo
- Bopaki
- Neuroblastoma
- Hlahala e Tiileng
- Bopaki
- LITLHAKU
- Kalafo ea Sele ea NK
- Myasthenia Gravis (MG)
- Leukemia e matla ea Lymphoblastic (B-ALL)
- Lupus Erythematosus ea Systemic (SLE)
- Leukemia e matla ea Lymphoblastic (T-ALL)
- Lymphoma e seng ea Hodgkin (NHL)
- Myeloma e mengata (MM)
- Ho Hasanya Lymphom e Kholo ea Lisele tsa B
- Leukemia ea B-lymphocytic
- Myeloma
Moshanyana ea loantšanang le leukemia e matla ea lymphoblastic
Tlhahisoleseding ea Motheo ea Mokuli
Monna ea lilemo li 16 ea fumanoeng a e-na le acute lymphoblastic leukemia (B-ALL), ea ileng a etsoa chemotherapy ea pele, kalafo ea lisele tsa CD19/22 CAR-T, chemotherapy ea salvage, le transplantation ea lisele tsa hematopoietic stem tse latelang (allo-HSCT) ho tsoa ho mofani oa motsoali.
Boemo ba Pele ho Kalafo ba Mokuli
Pele ho allo-HSCT, mokuli o ile a ba le keketseho e potlakileng ea lisele tse tšoeu tsa mali le lefu le sa khaotseng ho sa tsotellehe mekhoa e mengata ea ho kenella. Kamora ho kenngoa ha CD19/22 CAR-T ka la 21 Mmesa, 2025 (lisele tsohle tsa CAR-T: 6.5×10^7), palo ea lisele tsa CAR-T qalong e ile ea atolosoa ho fihlela ho 3.95×10^6/L ka letsatsi la 7 empa ea fokotseha ho ea ho 0.82×10^6/L ka letsatsi la 14, ka lisele tsa mali tse tsoang ka ntle li nyoloha ho tloha ho 28.6% ho ea ho 87.1%. Tlhahlobo ea moko oa masapo ka la 15 Mots'eanong, 2025, e senotse keketseho e fokotsehileng haholo ka 37.42% ea li-lymphoblast tse sa tloaelehang tsa B (tse hlahisang CD34, CD38/CD22 e sa fellang, CD81/CD19/CD33 e fokolang, e se nang CD10/CD20/CD79b), e tiisang hore ha ho pholiso. Mokelikeli oa boko o ne o sa bontše lisele tse sa tloaelehang, empa lefu ka kakaretso le ile la lula le sa imoloha.
Boemo ba Mokuli ka Mor'a Kalafo
Kamora allo-HSCT ka la 29-30 Mots'eanong, 2025 (lisele tsa CD34+: 8.6×10^6/kg; lisele tsa mononuclear: 8×10^8/kg), mokuli o fihletse neutrophil engraftment ka letsatsi la 11 le platelet engraftment ka letsatsi la 18. Letsatsing la 28 (Phuptjane 27, 2025), palo ea mali e ntlafetse haholo: hemoglobin 99 g/L (ho tloha maemong a tlase a pele), lisele tse tšoeu tsa mali 11.73×10^9/L, li-neutrophil 9.81×10^9/L, le li-platelet 79×10^9/L. Sebopeho sa moko oa masapo se bontšitse keketseho e mafolofolo ntle le lisele tse sa tloaelehang tsa pele, cytometry ea phallo e tiisitse hore ha ho na lintho tse sa tloaelehang, biopsy e bontšitse keketseho e tlase empa lisele tse bonahalang tsa trilineage ntle le li-lymphocyte tse sa butsoang, 'me STR chimerism e fihlile ho 100%, e fihlela remission e felletseng (CR) ka ho ba le negative e fokolang ea lefu (MRD-). Letsatsing la 49 (Phupu 18, 2025), moko oa masapo o ile oa lula o sebetsa ntle le lisele tse sa tloaelehang, tse tšehetsang CR le MRD-. Lefu le bobebe la graft-intestine ea sehlopha sa 1 le hlahile empa le ile la laoloa ka meriana, la bontša taolo e sebetsang ea lefu le ho hlaphoheloa ha le bapisoa le ho phatloha ho sa khaotseng pele ho kenngoa ha peo (ho tloha ho 37.42% ho isa ho 0%) le ho hloka phomolo.
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

